Reproducibility of endocrine disruption data

被引：15
作者：
Ashby, J
Elliott, BM
机构：
来源：
REGULATORY TOXICOLOGY AND PHARMACOLOGY | 1997年 / 26卷 / 01期
关键词：
D O I：
10.1006/rtph.1997.1157
中图分类号：
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号：
0301 ; 10 ;
摘要：
引用
收藏
页码：94 / 95
页数：2
相关论文
共 21 条
[1]   RETRACTED: Synergistic activation of estrogen receptor with combinations of environmental chemicals (Retracted Article) [J].
Arnold, SF ;
Klotz, DM ;
Collins, BM ;
Vonier, PM ;
Guillette, LJ ;
McLachlan, JA .
SCIENCE, 1996, 272 (5267) :1489-1492
[2]   Activity of raloxifene in immature and ovariectomized rat uterotrophic assays [J].
Ashby, J ;
Odum, J ;
Foster, JR .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1997, 25 (03) :226-231
[3]   Failure to confirm estrogenic activity for benzoic acid and clofibrate: Implications for lists of endocrine-disrupting agents [J].
Ashby, J ;
Lefevre, PA ;
Odum, J ;
Tinwell, H ;
Kennedy, SJ ;
Beresford, N ;
Sumpter, JP .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1997, 26 (01) :96-101
[4]   Synergy between synthetic oestrogens? [J].
Ashby, J ;
Lefevre, PA ;
Odum, J ;
Harris, CA ;
Routledge, EJ ;
Sumpter, JP .
NATURE, 1997, 385 (6616) :494-494
[5]   Normal sexual development of rats exposed to butyl benzyl phthalate from conception to weaning [J].
Ashby, J ;
Tinwell, H ;
Lefevre, PA ;
Odum, J ;
Paton, D ;
Millward, SW ;
Tittensor, S ;
Brooks, AN .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1997, 26 (01) :102-118
[6]  
ASHBY J, 1997, PROGR MUTATION RES, V394
[7]   RALOXIFENE (LY139481 HCL) PREVENTS BONE LOSS AND REDUCES SERUM-CHOLESTEROL WITHOUT CAUSING UTERINE HYPERTROPHY IN OVARIECTOMIZED RATS [J].
BLACK, LJ ;
SATO, M ;
ROWLEY, ER ;
MAGEE, DE ;
BEKELE, A ;
WILLIAMS, DC ;
CULLINAN, GJ ;
BENDELE, R ;
KAUFFMAN, RF ;
BENSCH, WR ;
FROLIK, CA ;
TERMINE, JD ;
BRYANT, HU .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (01) :63-69
[8]  
CHANDRA D, 1982, IND J PHYSL PHARM, V26, P148
[9]   GENOTOXICITY EVALUATION OF ESTRADIOL [J].
DHILLON, VS ;
DHILLON, IK .
MUTATION RESEARCH-GENETIC TOXICOLOGY, 1995, 345 (1-2) :87-95
[10]   Raloxifene inhibits bone turnover and prevents further cancellous bone loss in adult ovariectomized rats with established osteopenia [J].
Evans, GL ;
Bryant, HU ;
Magee, DE ;
Turner, RT .
ENDOCRINOLOGY, 1996, 137 (10) :4139-4144
123